Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-19 Sale |
2021-07-20 4:12 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $54.57 | $911,245 | 494,546 (Direct) |
View |
| 2021-07-12 Sale |
2021-07-14 4:50 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $54.9 | $405,527 | 171,589 (Direct) |
View |
| 2021-06-21 Sale |
2021-06-22 4:26 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $58.59 | $978,480 | 511,246 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-14 4:08 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $60.88 | $449,697 | 178,976 (Direct) |
View |
| 2021-05-19 Sale |
2021-05-20 7:52 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $55.71 | $930,276 | 527,946 (Direct) |
View |
| 2021-05-10 Sale |
2021-05-11 4:16 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $61.97 | $457,772 | 186,363 (Direct) |
View |
| 2021-04-19 Sale |
2021-04-21 4:14 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
16,700 | $57.63 | $962,433 | 544,646 (Direct) |
View |
| 2021-04-12 Sale |
2021-04-13 4:05 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $59.43 | $438,978 | 193,750 (Direct) |
View |
| 2021-03-22 Sale |
2021-03-24 4:05 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
16,700 | $68.49 | $1,143,860 | 640,365 (Direct) |
View |
| 2021-03-10 Sale |
2021-03-12 9:39 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Randolph Sophia Chief Medical Officer |
7,387 | $74.34 | $549,173 | 201,137 (Direct) |
View |
| 2020-12-14 Purchase |
2020-12-15 7:07 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
20,000 | $76 | $1,520,000 | 3,156,981 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-22 4:18 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Ventures II L.P. Lightstone Ventures II (A) L.P. LSV Associates II LLC Carusi Michael A George Jean Plain Henry A JR 10% Owner |
400,000 | $19 | $7,600,000 | 120,212 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 9:31 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner |
400,000 | $19 | $7,600,000 | 227,432 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 9:29 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Adelman Robert J venBio Global Strategic Fund L.P. venBio Global Strategic GP Ltd. venBio Global Strategic Fund II L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. See Remarks 10% Owner |
853,000 | $19 | $16,207,000 | 5,829,542 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 8:25 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
975,000 | $19 | $18,525,000 | 185,526 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 8:04 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
975,000 | $19 | $18,525,000 | 975,000 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 8:03 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
3,000 | $19 | $57,000 | 3,000 (Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 8:01 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Executive Chairman 10% Owner |
850,000 | $19 | $16,150,000 | 515,894 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:59 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pietzke Steffen VP Fin & Chief Acct Officer |
3,000 | $19 | $57,000 | 3,000 (Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:57 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
3,000 | $19 | $57,000 | 3,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-30 Option Award |
2021-08-03 5:12 pm |
N/A 2031-07-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-03 5:04 pm |
N/A 2031-07-29 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
225,000 | $0 | 225,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 7:03 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 6:59 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Nielsen Jack Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 6:54 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 6:50 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 6:45 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-05-03 Option Award(A) |
2021-05-19 5:26 pm |
N/A 2031-05-03 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2020-05-03 Option Award |
2021-05-05 4:29 pm |
N/A 2030-05-03 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly VP, Finance and CAO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-03-25 Exercise |
2021-03-26 9:39 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0.99 | 803,525 (Direct) |
View |
| 2021-03-25 Exercise |
2021-03-26 9:39 pm |
N/A 2027-03-30 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0 | 803,525 (Direct) |
View |
| 2021-03-22 Exercise |
2021-03-24 4:05 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
16,700 | $1.91 | 640,365 (Direct) |
View |
| 2021-03-22 Exercise |
2021-03-24 4:05 pm |
N/A 2029-09-12 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
16,700 | $0 | 640,365 (Direct) |
View |
| 2021-01-28 Exercise |
2021-01-29 4:15 pm |
N/A 2030-03-09 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
6,128 | $0 | 255,255 (Direct) |
View |
| 2021-01-28 Exercise |
2021-01-29 4:15 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | GARCIA PETER S Chief Financial Officer |
6,128 | $4.08 | 255,255 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-28 06:01 am |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0.99 | 803,525 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-28 06:01 am |
N/A 2027-03-30 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President & CEO |
10,000 | $0 | 803,525 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-22 4:18 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Ventures II L.P. Lightstone Ventures II (A) L.P. LSV Associates II LLC Carusi Michael A George Jean Plain Henry A JR 10% Owner |
7,360,342 | $0 | 120,212 (Indirect) |
View |
Ownership(A) |
2020-07-22 4:15 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Ventures II L.P. Lightstone Ventures II (A) L.P. LSV Associates II LLC Carusi Michael A George Jean Plain Henry A JR 10% Owner |
0 | $0 | 3,669,171 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 9:31 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner |
7,537,750 | $0 | 227,432 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 9:29 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Adelman Robert J venBio Global Strategic Fund L.P. venBio Global Strategic GP Ltd. venBio Global Strategic Fund II L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. See Remarks 10% Owner |
11,062,093 | $0 | 5,829,542 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 8:25 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
6,403,899 | $0 | 185,526 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 8:04 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
2,105,901 | $0 | 975,000 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 8:01 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Executive Chairman 10% Owner |
11,224,503 | $0 | 515,894 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:56 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Caffo Nathan Chief Business Officer |
10,529 | $0 | 11,254 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:54 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume President and CEO |
54,584 | $0 | 541,346 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-17 7:10 pm |
N/A 2030-07-16 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
24,009 | $0 | 24,009 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-17 7:08 pm |
N/A 2030-07-16 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Nielsen Jack Director |
24,009 | $0 | 24,009 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-17 7:06 pm |
N/A 2030-07-16 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason Director 10% Owner |
24,009 | $0 | 24,009 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-17 7:05 pm |
N/A 2030-07-16 |
ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Executive Chairman 10% Owner |
24,009 | $0 | 24,009 (Direct) |
View |